Matt Henriksen

Yeah.

And that's probably why now you just see the Dexcom and the Abbott's of the world being able to dominate the market because they've been able to establish that type of stabilizing chemistry, as you mentioned.

With those two in the market, they're mainly in the type one space and they're starting to get into the type two diabetic patient population.

How has that patient opportunity changed throughout the years?

And I think we'll definitely jump into how to integrate all those into one device, because even when you mentioned the ring, the watch, all those things,

One of the reasons why I haven't personally gone into those is because I'm like well Do I need ten different apps for ten different readings?

So I definitely I'm gonna be personally curious about that going back to the the context for type two is it just as simple as you know, I Had an extra bagel for breakfast and I see that rise in the glucose measurements Therefore, I know I need to fix my diet better to be able to maintain the time and range and

Or is there more complicated understanding of the glucose health for these patients?

Yeah.

Or I was even thinking like, oh, how much orange juice could I drink before it gets yellow?

Which is another kind of same thing, cognitive understanding of how your body's working and everything.

There you go.

If I'm out here at the recording studio and I have a spike because I drank some juice, I would miss out on it.

And then even something too, like, oh, if I eat the bagel before I run or if I run before the bagel, you can see the trends and how that differs and everything.

Yeah.

That's a perfect segue.

Let's jump into the tool now, the Shine.

How did that development process start?

It's not simply, I can work on this overnight as my PhD project and get it done.

What was the process to kind of develop and understand that this could work as a viable sensor?